Stereotaxis Inc. secured U.S. FDA approval for its Magic magnetic interventional ablation catheter, marking a key step in the ...

A would-be psoriasis winner began taking more distinct shape in the competitive oral tyrosine kinase 2 (TYK2) inhibitor space ...

Excessive production of pro-inflammatory cytokines or aging-related chronic inflammation disrupts immunity and diminishes the ...

Sustaining healthy weight loss is about much more than cutting calories or injecting drugs, as many glucagon-like peptide-1 ...

Nia Therapeutics Inc. reported data from an in vivo study of its Smart Neurostimulation System, an AI-based brain-computer ...

The U.K. National Institute for Health and Care Excellence posted a draft update on its recommendations for ovarian cancer ...

Australia’s Therapeutic Goods Administration posted a proposed rework of the agency’s conformity assessment procedures that ...

Insilico Medicine Cayman Topco has announced a multiyear research and development collaboration with Laboratoires Servier SAS ...

Unless the U.S. Supreme Court steps in to reverse the decision, the NIH’s attempt to cap indirect costs at 15% in all its grants is dead. The U.S. Court of Appeals for the First Circuit upheld a ...

South Korea’s National Assembly approved the largest budgets for its health ministries in 2026, including the Ministry of Health and Welfare, Ministry of Food and Drug Safety and Korea Disease Control ...

Pacific including deals and partnerships, grants, preclinical data and other news in brief: Adlai Nortye, Arbormed Harbour Biomed, Biogen, Hyloris, Juangsu Aosaikang, Samsung,Takeda Pharmaceutical, ...

Innocan Pharma Corp., of Herzliya, Israel, plans to list on the NYSE American exchange on or around Jan. 7, 2026, and is also conducting a concurrent offering of securities subject to market ...